Unicycive Therapeutics
UNCY
UNCY
15 hedge funds and large institutions have $1.38M invested in Unicycive Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
61% less capital invested
Capital invested by funds: $3.54M → $1.38M (-$2.17M)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$123K | |
2 | +$25.6K | |
3 | +$19.4K | |
4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$18.5K |
5 |
UBS Group
Zurich,
Switzerland
|
+$1.5K |
Top Sellers
1 | -$1.51M | |
2 | -$37.3K | |
3 | -$24.1K | |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.73K |
5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2 |